EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -20.0% | 16,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $5,000 | -44.4% | 16,000 | -20.0% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | +50.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | -45.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | +37.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | -61.9% | 20,000 | 0.0% | 0.00% | -66.7% |
| Q4 2017 | $21,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,616,000 | $1,891,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 46,378 | $54,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 32,022 | $37,000 | 0.00% |
| Vantage Investment Advisors, LLC | 6,500 | $8,000 | 0.00% |
| IFP Advisors, Inc | 25,800 | $30,000 | 0.00% |
| Virtu Financial LLC | 15,967 | $19,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 524 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,277 | $13,000 | 0.00% |
| CREDIT SUISSE AG/ | 30,000 | $35,000 | 0.00% |